PEPTIDEREPORT

Peer reviewed

Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion

Therapeutic benefits of methylene blue on cognitive impairment during chronic cerebral hypoperfusion

PubMed / NCBIAccessed Aug 2, 2026

Open original source

Registry record

Source metadata

Publisher
PubMed / NCBI
Source type
Peer reviewed
Registry ID
pubmed-methylene-blue-cognitive-2014
PMID
25079810

Source usage

Linked from 3 pages

Compound

Methylene Blue

Evidence curation

Best Compounds for Mitochondrial Research

Guide

Peptide Category Explainers: How Every Compound Class on This Site Is Defined

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.